LONZA WALKERSVILLE, INC.

Lonza is a Swiss multinational contract development and manufacturing organization (CDMO) founded in 1897, headquartered in Basel. The company operates 30+ development and manufacturing sites globally and employs approximately 20,000 colleagues across five continents. As the pioneer and world leader in the CDMO industry, Lonza specializes in biopharmaceutical manufacturing and offers integrated services across biologics development, mammalian cell culture systems, small molecules and highly potent active pharmaceutical ingredients (HPAPIs), bioconjugates, cell and gene therapies (CGT), advanced mRNA technologies, and specialized modalities. The company also manufactures pharmaceutical capsules and health ingredients for nutraceutical applications. Lonza provides end-to-end support from drug development through manufacturing and commercialization, serving major pharmaceutical and biotechnology customers globally. Notable partnerships include production collaboration with Moderna for COVID-19 vaccine manufacturing.